ONC
BeOne MedicinesDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Composite grade D from latest DB weights. Momentum 28.1 / Value 59.5
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.3.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
28
Value
60
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $417.56
Why
Momentum28 · Δ7d -10.4
Value60 · Δ7d +0.3
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
28
52% active weight
Current posture
7d trendSoftening
Δ7d
-10.4
Δ21d
-0.4
Value
60
48% active weight
Current posture
7d trendFlat
Δ7d
+0.3
Δ21d
+0.6
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 28.1 / Value 59.5
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$32.05B
Beta
0.52
Shares Out
1.55B
P/E (TTM)
615.3
P/S (TTM)
8.15
P/FCF (TTM)
87.32
Rev YoY
+41.1%
EPS YoY
+175.8%
Gross Margin
+86.0%
Op Margin
+2.2%
Net Debt
-$1.56B
Current Ratio
2.39
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology